The role of viruses in acute exacerbations of asthma

[1]  S. Johnston,et al.  Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-&kgr;B and EGFR pathways , 2010, European Respiratory Journal.

[2]  S. Johnston,et al.  Azithromycin induces anti-viral responses in bronchial epithelial cells , 2010, European Respiratory Journal.

[3]  S. Keleş,et al.  Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma , 2010, Mucosal Immunology.

[4]  Ying Zhao,et al.  CXCR2 Is Required for Neutrophilic Airway Inflammation and Hyperresponsiveness in a Mouse Model of Human Rhinovirus Infection1 , 2009, The Journal of Immunology.

[5]  N. Papadopoulos,et al.  Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  Rosanna Lagos,et al.  SAFETY AND ANTIVIRAL ACTIVITY OF MOTAVIZUMAB, A RESPIRATORY SYNCYTIAL VIRUS (RSV)–SPECIFIC HUMANIZED MONOCLONAL ANTIBODY, WHEN ADMINISTERED TO RSV-INFECTED CHILDREN , 2009, The Pediatric infectious disease journal.

[7]  P. Sly,et al.  Toll-like receptor 7 function is reduced in adolescents with asthma , 2009, European Respiratory Journal.

[8]  Wai-ming Lee,et al.  Rhinovirus-induced Major Airway Mucin Production Involves a Novel Tlr3-egfr–dependent Pathway , 2009 .

[9]  S. Holgate,et al.  Contribution of Bronchial Fibroblasts to the Antiviral Response in Asthma1 , 2009, The Journal of Immunology.

[10]  P. Bardin,et al.  Transforming growth factor-beta enhances rhinovirus infection by diminishing early innate responses. , 2009, American journal of respiratory cell and molecular biology.

[11]  D. Kwiatkowski,et al.  Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster , 2009, Thorax.

[12]  D. Kwiatkowski,et al.  Genetic association study for RSV bronchiolitis in infancy at the 5 q 31 cytokine cluster , 2009 .

[13]  E. De Clercq,et al.  Selective inhibitors of picornavirus replication , 2008, Medicinal research reviews.

[14]  S. Johnston,et al.  Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production , 2008, Proceedings of the National Academy of Sciences.

[15]  S. Johnston,et al.  Deficient interferon in virus‐induced asthma exacerbations , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  J. Ceuppens,et al.  Type III IFN‐λ mRNA expression in sputum of adult and school‐aged asthmatics , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[17]  M. Nyegaard,et al.  Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders , 2008, Thorax.

[18]  D. Proud,et al.  Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. , 2008, The Journal of allergy and clinical immunology.

[19]  S. Weiland,et al.  IRF-1 gene variations influence IgE regulation and atopy. , 2008, American journal of respiratory and critical care medicine.

[20]  F. Schelcher,et al.  Human and bovine respiratory syncytial virus vaccine research and development. , 2008, Comparative immunology, microbiology and infectious diseases.

[21]  M. McGuckin,et al.  Structure and function of the polymeric mucins in airways mucus. , 2008, Annual review of physiology.

[22]  S. Johnston,et al.  Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages , 2008, Thorax.

[23]  R. A. Killington,et al.  Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation , 2008, Nature Medicine.

[24]  C. Schans,et al.  Bronchial mucus transport , 2007 .

[25]  S. Phipps,et al.  Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. , 2007, Blood.

[26]  B. O'connor,et al.  Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. , 2007, American journal of respiratory and critical care medicine.

[27]  S. Johnston,et al.  IFN-γ–induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations , 2007, Journal of Allergy and Clinical Immunology.

[28]  J. Blic.  Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial, F. Tahan, A. Ozcan, N. Koc, in: Eur Respir J, 29. (2007), 91 , 2007 .

[29]  D. Broide,et al.  Inhibition of Allergen-Induced Airway Remodeling in Smad 3-Deficient Mice1 , 2007, The Journal of Immunology.

[30]  S. Johnston,et al.  Corticosteroids and β2 Agonists Differentially Regulate Rhinovirus-induced Interleukin-6 via Distinct Cis-acting Elements* , 2007, Journal of Biological Chemistry.

[31]  Herren Wu,et al.  Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. , 2007, Journal of molecular biology.

[32]  Yusuke Nakamura,et al.  Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma. , 2007, American journal of respiratory cell and molecular biology.

[33]  W. Teague,et al.  Prevalence of viral respiratory tract infections in children with asthma , 2006, Journal of Allergy and Clinical Immunology.

[34]  F. Tahan,et al.  Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial , 2006, European Respiratory Journal.

[35]  E. Simões,et al.  Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. , 2007, The Journal of pediatrics.

[36]  C. P. Van der Schans.  Bronchial mucus transport. , 2007, Respiratory care.

[37]  H. Kubo,et al.  Mechanisms of mucin production by rhinovirus infection in cultured human airway epithelial cells , 2006, Respiratory Physiology & Neurobiology.

[38]  S. Psarras,et al.  Synergistic effects of fluticasone propionate and salmeterol on inhibiting rhinovirus‐induced epithelial production of remodelling‐associated growth factors , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[39]  S. Johnston,et al.  Rhinovirus Replication in Human Macrophages Induces NF-κB-Dependent Tumor Necrosis Factor Alpha Production , 2006, Journal of Virology.

[40]  Stephen T Holgate,et al.  Role of deficient type III interferon-λ production in asthma exacerbations , 2006, Nature Medicine.

[41]  B. Nicholas,et al.  Shotgun proteomic analysis of human‐induced sputum , 2006, Proteomics.

[42]  E. Walters,et al.  Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. , 2006, American journal of respiratory and critical care medicine.

[43]  S. Johnston.  Macrolide antibiotics and asthma treatment. , 2006, The Journal of allergy and clinical immunology.

[44]  S. Johnston,et al.  Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection , 2006, Respiratory research.

[45]  S. Johnston,et al.  The effect of telithromycin in acute exacerbations of asthma. , 2006, The New England journal of medicine.

[46]  A. Bufe,et al.  Impaired virus‐induced interferon‐α2 release in adult asthmatic patients , 2006 .

[47]  P. Österlund,et al.  TNF-α and IFN-α enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells , 2006 .

[48]  S. Johnston,et al.  Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells. , 2006, American journal of respiratory cell and molecular biology.

[49]  Y. Jang,et al.  Effect of clarithromycin on rhinovirus-16 infection in A549 cells , 2006, European Respiratory Journal.

[50]  S. Johnston,et al.  Role of deficient type III interferon-lambda production in asthma exacerbations. , 2006, Nature medicine.

[51]  K. Melén,et al.  TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. , 2006, Virology.

[52]  A. Bufe,et al.  Impaired virus-induced interferon-alpha2 release in adult asthmatic patients. , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[53]  C. Sousa.  Faculty Opinions recommendation of Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. , 2005 .

[54]  A. Al-ghonaium,et al.  Human TLR-7-, -8-, and -9-Mediated Induction of IFN-α/β and -λ Is IRAK-4 Dependent and Redundant for Protective Immunity to Viruses , 2005, Immunity.

[55]  O. Ramilo,et al.  Respiratory Syncytial Virus Infections: Old Challenges and New Opportunities , 2005, The Pediatric infectious disease journal.

[56]  S. Johnston,et al.  Toll-Like Receptor 3 Is Induced by and Mediates Antiviral Activity against Rhinovirus Infection of Human Bronchial Epithelial Cells , 2005, Journal of Virology.

[57]  P. Gibson,et al.  Interleukin-10 gene expression in acute virus-induced asthma. , 2005, American journal of respiratory and critical care medicine.

[58]  D. Proud,et al.  Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[59]  F. Maldonado,et al.  In Vitro Antiviral Activity and Single-Dose Pharmacokinetics in Humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease , 2005, Antimicrobial Agents and Chemotherapy.

[60]  R. Karron,et al.  Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. , 2005, The Journal of infectious diseases.

[61]  H. Donninger,et al.  Rhinovirus infects primary human airway fibroblasts and induces a neutrophil chemokine and a permeability factor , 2005, Journal of medical virology.

[62]  S. Johnston,et al.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus , 2005, The Journal of experimental medicine.

[63]  C. Duckett,et al.  Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression , 2005, Journal of Virology.

[64]  R. Flavell,et al.  Toll-like receptor 3 promotes cross-priming to virus-infected cells , 2005, Nature.

[65]  Guanghui Hu,et al.  Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts. , 2005, The Journal of allergy and clinical immunology.

[66]  D. Matthews,et al.  Conservation of Amino Acids in Human Rhinovirus 3C Protease Correlates with Broad-Spectrum Antiviral Activity of Rupintrivir, a Novel Human Rhinovirus 3C Protease Inhibitor , 2005, Antimicrobial Agents and Chemotherapy.

[67]  R. Homer,et al.  Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung , 2004, Nature Medicine.

[68]  Jian Zheng,et al.  Induction of mucin secretion from human bronchial tissue and epithelial cells by rhinovirus and lipopolysaccharide. , 2004, Acta pharmacologica Sinica.

[69]  F. Schmitz,et al.  Herpes simplex virus type-1 induces IFN-α production via Toll-like receptor 9-dependent and -independent pathways , 2004 .

[70]  R. Flavell,et al.  Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[71]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[72]  F. Schmitz,et al.  Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[73]  M. Abe,et al.  Rhinovirus 16 3C Protease Induces Interleukin-8 and Granulocyte-Macrophage Colony-Stimulating Factor Expression in Human Bronchial Epithelial Cells , 2004, Pediatric Research.

[74]  H. Simon,et al.  Clinical and immunological effects of low‐dose IFN‐α treatment in patients with corticosteroid‐resistant asthma , 2003, Allergy.

[75]  Isabelle Vachier,et al.  Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. , 2003, American journal of respiratory and critical care medicine.

[76]  E. D. de KLERK,et al.  Interleukin‐1β and interleukin‐1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non‐asthmatic subjects , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[77]  S. Johnston,et al.  Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. , 2003, American journal of respiratory and critical care medicine.

[78]  R. Wood,et al.  FREQUENCY, SEVERITY, AND DURATION OF RHINOVIRUS INFECTIONS IN ASTHMATIC AND NONASTHMATIC INDIVIDUALS: A LONGITUDINAL COHORT STUDY , 2003, Pediatrics.

[79]  P. Paré,et al.  Characterization of airway plugging in fatal asthma. , 2003, The American journal of medicine.

[80]  H. Donninger,et al.  Rhinovirus induction of the CXC chemokine epithelial-neutrophil activating peptide-78 in bronchial epithelium. , 2003, The Journal of infectious diseases.

[81]  J. Bousquet,et al.  Clinical and biological heterogeneity in children with moderate asthma. , 2003, American journal of respiratory and critical care medicine.

[82]  A. Fendrick,et al.  The economic burden of non-influenza-related viral respiratory tract infection in the United States. , 2003, Archives of internal medicine.

[83]  S. French,et al.  Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. , 2003, Journal of immunology.

[84]  D. Rogers.  The airway goblet cell. , 2003, The international journal of biochemistry & cell biology.

[85]  J. Gern.  Rhinovirus respiratory infections and asthma. , 2002, The American journal of medicine.

[86]  Stephen T Holgate,et al.  Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study , 2002, The Lancet.

[87]  Bo Liu,et al.  Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics. , 2002, Journal of medicinal chemistry.

[88]  P. Gibson,et al.  Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma , 2002, European Respiratory Journal.

[89]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[90]  X. Liu,et al.  Activation of NF-kappa B in bronchial epithelial cells from children with asthma. , 2001, Chinese medical journal.

[91]  S. Holgate,et al.  Rhinovirus infection up‐regulates eotaxin and eotaxin‐2 expression in bronchial epithelial cells , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[92]  W. Busse,et al.  Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. , 2000, American journal of respiratory and critical care medicine.

[93]  Douglas T. Golenbock,et al.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.

[94]  V. Casolaro,et al.  Role of NF-κB in Cytokine Production Induced from Human Airway Epithelial Cells by Rhinovirus Infection1 , 2000, The Journal of Immunology.

[95]  J. V. van Krieken,et al.  Experimental rhinovirus 16 infection increases intercellular adhesion molecule‐1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[96]  W. Busse,et al.  The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. , 2000, The Journal of allergy and clinical immunology.

[97]  N. Papadopoulos,et al.  Rhinoviruses infect the lower airways. , 2000, The Journal of infectious diseases.

[98]  N. Papadopoulos,et al.  Corticosteroids inhibit rhinovirus-induced intercellular adhesion molecule-1 up-regulation and promoter activation on respiratory epithelial cells. , 2000, The Journal of allergy and clinical immunology.

[99]  S. Johnston,et al.  Respiratory Epithelial Cell Expression of Vascular Cell Adhesion Molecule-1 and Its Up-regulation by Rhinovirus Infection via NF-κB and GATA Transcription Factors* , 1999, The Journal of Biological Chemistry.

[100]  P. Stjärne,et al.  LTB(4)-induced nasal gland serous cell secretion mediated by neutrophil elastase. , 1999, American journal of respiratory and critical care medicine.

[101]  H. Boushey,et al.  Rhinovirus-16 colds in healthy and in asthmatic subjects: similar changes in upper and lower airways. , 1999, American journal of respiratory and critical care medicine.

[102]  M. Schroth,et al.  Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. , 1999, American journal of respiratory cell and molecular biology.

[103]  F. Hayden,et al.  Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. , 1999, JAMA.

[104]  S. Johnston,et al.  Rhinovirus Infection Induces Expression of Its Own Receptor Intercellular Adhesion Molecule 1 (ICAM-1) via Increased NF-κB-mediated Transcription* , 1999, The Journal of Biological Chemistry.

[105]  S. Johnston,et al.  RANTES, Macrophage-Inhibitory Protein 1α, and the Eosinophil Product Major Basic Protein Are Released into Upper Respiratory Secretions during Virus-Induced Asthma Exacerbations in Children , 1999, The Journal of infectious diseases.

[106]  I. Adcock,et al.  Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. , 1998, American journal of respiratory and critical care medicine.

[107]  S. Johnston,et al.  Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. , 1998, American journal of respiratory and critical care medicine.

[108]  J. Friedland,et al.  Respiratory Syncytial Virus-Induced RANTES Production from Human Bronchial Epithelial Cells Is Dependent on Nuclear Factor-κB Nuclear Binding and Is Inhibited by Adenovirus-Mediated Expression of Inhibitor of κBα , 1998, The Journal of Immunology.

[109]  W. Busse,et al.  Eosinophils bind rhinovirus and activate virus-specific T cells. , 1998, Journal of immunology.

[110]  J. Friedland,et al.  Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha. , 1998, Journal of immunology.

[111]  Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. , 1998, Pediatrics.

[112]  J. Elias,et al.  Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. , 1997, The American journal of physiology.

[113]  K. Nakayama,et al.  Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta. , 1997, The American journal of physiology.

[114]  Weiliang Tang,et al.  Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-κB. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[115]  M. Yamaya,et al.  Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[116]  R. Martin,et al.  Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. , 1997, American journal of respiratory cell and molecular biology.

[117]  P. Howarth,et al.  Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. , 1997, American journal of respiratory and critical care medicine.

[118]  E. D. de KLERK,et al.  Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. , 1997, American journal of respiratory and critical care medicine.

[119]  J. Wilson,et al.  Increased vascularity of the bronchial mucosa in mild asthma. , 1997, American journal of respiratory and critical care medicine.

[120]  S. Johnston,et al.  Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. , 1997, American journal of respiratory and critical care medicine.

[121]  E. D. de KLERK,et al.  Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin‐8 in nasal lavage in asthmatic subjects in vivo , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[122]  W. Calhoun,et al.  Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. , 1997, American journal of respiratory and critical care medicine.

[123]  W. Busse,et al.  Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. , 1996, Journal of immunology.

[124]  J. Gwaltney,et al.  The influence of signal variation, bias, noise and effect size on statistical significance in treatment studies of the common cold. , 1996, Antiviral research.

[125]  J. Elias,et al.  Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. , 1996, The Journal of clinical investigation.

[126]  Stephen T Holgate,et al.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.

[127]  P. Heymann,et al.  Assessment of eosinophils, viruses and IgE antibody in wheezing infants and children. , 1995, International archives of allergy and immunology.

[128]  S. Johnston,et al.  Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. , 1995, American journal of respiratory and critical care medicine.

[129]  T. Maniatis,et al.  NF-κB: A lesson in family values , 1995, Cell.

[130]  T. Maniatis,et al.  NF-kappa B: a lesson in family values. , 1995, Cell.

[131]  W. Busse,et al.  A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. , 1994, The Journal of clinical investigation.

[132]  S. Johnston,et al.  Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. , 1994, American journal of respiratory cell and molecular biology.

[133]  K. Nicholson,et al.  Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.

[134]  P. Holt,et al.  Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages , 1993, The Journal of experimental medicine.

[135]  R. Garofalo,et al.  Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. , 1992, The Journal of pediatrics.

[136]  P. Holt.  Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages. , 1986, Clinical and experimental immunology.

[137]  F. Hayden,et al.  Intranasal Interferon-α2, Treatment of Experimental Rhinoviral Colds , 1984 .

[138]  F. Hayden,et al.  Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds. , 1984, The Journal of infectious diseases.

[139]  G. Scott,et al.  PREVENTION OF RHINOVIRUS COLDS BY HUMAN INTERFERON ALPHA-2 FROM ESCHERICHIA COLI , 1982, The Lancet.

[140]  C. Reed,et al.  Viruses as precipitants of asthmatic attacks in children. , 1974, JAMA.

[141]  H. Lambert,et al.  Infective Factors in Exacerbations of Bronchitis and Asthma , 1972, British medical journal.

[142]  W. Aherne,et al.  Pathological changes in virus infections of the lower respiratory tract in children , 1970, Journal of clinical pathology.